Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Healthcare Cannabis
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.


CSE:COOL - Post by User

Core One Labs Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Stranius75on Jun 10, 2018 11:31am
76 Views
Post# 28151481

RE:RE:RE:RE:RE:RE:RE:RE:Its been a bumpy ride to say the least

RE:RE:RE:RE:RE:RE:RE:RE:Its been a bumpy ride to say the leastLDS are wrong along with their patent lawyers eh. Regardless , that guy at CTT likes to file patents patents without substance. He’s been doing it over 20 years but makes nothing.  Personally , it appears he filed some BS with a small amount opioids also being used in some strip but nothing in his patent about the ingredients used just some chemistry as to how it should.  Now take a hike before I come to the CTT board and ruin your life      
thcalternative1 wrote: Brad is in denial....his retraction regarding the CTT patents was again misleading. There is no "overlap" in patents.


CTTH has 5 patents issued, 1 pending and 2 Worldwide!

LDS has ZERO patents issued.

LDS better off with a qualified CEO who can speak the truth not falsehoods.

How can Brad be replaced should be the theme of LDS shareholders.

Re-hire Brad to sell the oils under a new leader


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities